NCT01470274View on ClinicalTrials.gov

Safety of the CO-rebreathing Method in Stable Coronary Artery Disease and COPD Patients

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

February 29, 2012

Conditions
Cardiovascular DiseaseChronic Obstructive Pulmonary Disease
Trial Locations (1)

7489

Norwegian University of Science and Technology, Trondheim

All Listed Sponsors
lead

Norwegian University of Science and Technology

OTHER

NCT01470274 - Safety of the CO-rebreathing Method in Stable Coronary Artery Disease and COPD Patients | Biotech Hunter | Biotech Hunter